Lung Working Group
The Lung Working Group, led by physicians, Dr. Shruti Jolly (Michigan Medicine/MROQC Coordinating Center) and Dr. Garth Tormoen (West Michigan Cancer Center), and medical physicist, Dr. Martha Matuszak (Michigan Medicine/MROQC Coordinating Center), is currently working to identify ways to improve lung cancer treatment for patients across the state of Michigan.
Lung Working Group Meetings occur on the Third Monday of the month from 12:00pm - 1:00pm
Areas of Current and Ongoing Focus
-
Treatment technique and lung/esophagus toxicity evaluation (IMRT vs. 3DCRT)
-
Impact of pretreatment cardiac disease and radiation doses on long term heart complications
-
​Understanding factors that contribute to poor patient outcomes post lung cancer treatment
-
​Uptake and toxicity implications of Immunotherapy in definitive lung cancer treatment
-
Disparities in Lung Cancer Care
-
Improving Quality of Radiation Treatment Plan and Delivery
-
Lung Target Delineation
-
Lung Target Coverage and Normal Tissue Dose Constraints
-
Lung Motion Assessment
-
Knowledge-Based Planning (KBP) to improve radiation plan quality
Tools: MROQC Lung Pneumonitis Prediction App
